Pharmacogenetics-based AUC prediction model may determine the optimal initial dose of axitinib in renal cell carcinoma

Yoshiaki Yamamoto
Ryouichi Tsunedomi
Yusuke Fujita
Hiroaki Matsumoto
Yoshihiko Hamamoto
Shoichi Hazama
Hiroaki Nagano
Hideyasu Matsuyama

第77回日本癌学会学術総会